choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Byetta

Byetta Newsletter
  • Byetta interactions: Alcohol, medications, and other factors 03 Jun 2025 12:43 GMT

    Byetta treatment, talk with your doctor. Here’s a closer look at certain drugpills Byetta interacts with birth control pills. In addition to preventing pregnancy, these medications … ’t been enough clinical trials to determine whether Byetta is safe to …

  • Americans Spent $71 Billion on Drugs Like Ozempic in 2023 31 May 2025 19:31 GMT

    … products, like Victoza, Bydureon and Byetta, actually decreased by $4 billion … weight loss: One 2022 clinical trial found that patients lost an … treatment, the Food and Drug Administration (FDA) approved Wegovy — which contains an identical medication

  • How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race 30 May 2025 09:50 GMT

    … . While these drugs followed Eli Lilly’s Byetta (2005) and … the demand for obesity medication was going to be.” … treatment yielded 22.7% weight loss, missing its 25% forecast. Subsequent trial … diabetes trial. Investors await the pill’s Phase 3 trial results …

  • Can GLP-1 Receptor Agonists Curb Cancer? Study Links Drugs to Reduced Risk in Obesity-Related Cases 23 May 2025 06:16 GMT

    … Mavromatis, ScB, a medical student at the NYU … trial raises an intriguing hypothesis: that the increasingly popular GLP-1 medicationsdrugs produced some weight loss: these included exenatide (Byetta), … . But ASCO Chief Medical Officer Julie R. Gralow …

  • GLP-1 RA medications safe and effective for treating obesity in adults with mental illness: Study 23 May 2025 01:53 GMT

    … mood-altering drugs (psychotropics), which include antidepressants and antipsychotics, … who must take their medications indefinitely to reduce … reported in a randomised trial of liraglutide (up … large-scale randomised trials and longer treatment and follow- …

  • GLP-1 Drugs Appear To Lower Cancer Risk 19 May 2025 11:37 GMT

    … GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were … many other benefits that these medications provide,” lead researcher Dr … effects of GLP-1 (drugs) against obesity-related cancers … at Hasharon Hospital-Rabin Medical Center at Petah Tikva, …

  • Patients taking newer weight loss drugs likely to return to their original weight within 2 years, study ays 17 May 2025 00:52 GMT

    … both new and older medications — one study concerning Byetta and seven concerning … ) per month, after stopping the drug. Reviewers estimated the return to … of these medications without a more comprehensive approach to the treatment of …

  • Weight-loss drugs’ impact on cancer risk revealed in new study 14 May 2025 09:37 GMT

    … cause certain cancers, and treatment of obesity with GLP1-RA … ," the Minnesota-based doctor, who also was not … LATE-PHASE TRIAL Research suggests that GLP-1 medications help reduce … numbers of people taking exenatide (Byetta) and dulaglutide (Trulicity). …

  • Weight Loss Drugs Show Increasing Benefit in Skin Disease 14 May 2025 09:36 GMT

    … GLP-1 RA) medications began as treatments for type 2 diabetes … weight loss) and exenatide (Byetta for T2D). More recently, … meta-analysis of four trials of 32 patients with … Foundation, Neuroderm LTD, Novartis Pharmaceuticals, Oruka Therapeutics, Pfizer, UCB …

  • Weight-Loss Drugs Could Slash Cancer Risk by 41%—Here’s Who Benefits 13 May 2025 13:30 GMT

    … and not—of popular medications like Wegovy, Ozempic, … drugs liraglutide (prescribed under the brand names Victoza and Saxenda), exenatide (Byetta … head of the Internal Medicine, Department and Obesity clinic … of randomized trials and larger prospective studies …

Satisfied with the content?

Continue to create your account.